DAY 1 SESSIONS

Alphabet Soup: Making Sense of New MOAs (Whiteboard Panel)Faculty outline BTK, OX-40, JAK, TYK pathways live (using whiteboards and/or animations depending on timing), walking attendees through mechanism, clinical impact, and “who is the right patient.” Includes simple analogies and short patient scripts.

Itch Interrupted: Targeting the Neuroimmune Axis in PN & CSU (Case Study Panel)
Prurigo nodularis and CSU cases illustrate itch pathophysiology, current and emerging therapies, and practical communication with patients about expectations and safety.

Targeted Topicals: The Science and Strategy behind Nonsteroidal Innovation (Case Study Panel)
Case-based review of nonsteroidal options, how to layer them with systemics and biologics, and when they can prevent escalation or complement advanced therapies.

Cross Talk: Immune Pathways in Vitiligo & Alopecia Areata (Multi-discipline Panel)
Panel maps shared immune drivers and discusses therapeutic overlap, sequencing, and what to watch for across these two conditions.

The Hidden Disease: Recognizing, Treating & Supporting Patients with HS (Small-Group Discussion in Main Room)
Guided discussions at tables on early recognition, staging, comorbidities, pain and stigma, and treatment pathways for HS.

DAY 2 SESSIONS

(Rheum Connection) Beyond the Skin: How Treating Inflammation Improves Comorbidities (Panel)
Reviews evidence for systemic benefits of inflammatory control (cardiometabolic, joint, mental health) and how to communicate these benefits to patients.

(GI Connection) Red Flags in the Exam Room: Systemic Clues Not to Miss (Case Study Panel)
Rapid-fire cases highlight GI, rheumatologic, and systemic warning signs that should prompt further workup or referral.

The Derm-Allergy Connection: Where Our Patients Overlap

Cytokine Signaling in AD, overlapping AD, allergic triad, CSU, eosinophilia patterns, and when to patch/skin test, order labs, or refer to allergy.

The Psychoderm Connection: Mental Burden of Skin Disease
Discusses mental health impact, screening for depression/anxiety, sleep, and how reducing inflammation can improve psychological outcomes.